(REGISTER CLOSED) 58th Breakfast Meeting: Recent Developments in Health Technology Assessments (tentative title)
date : 5/9/2016
Please note that this event will be held only in Japanese
■Speraker:
Dr. Ataru Igarashi
(Assistant Professor at The University of Tokyo’s Graduate School of Pharmaceutical Sciences)
■Date & Time:
Thursday, Jun 2, 2016 8:00-9:15am (Doors open 7:45am)
■Venue:
EGG JAPAN
(10th floor, Shin-Marunouchi Building, 1-5-1 Marunouchi, Chiyoda-ku, Tokyo)
■Participation fee:
General: 2,500 JPN Yen
Students: 1,500 JPN Yen for students (Student ID required)
Individual supporting members: Free
■Summary:
There has recently been more and more movement toward the introduction of Health Technology Assessments (HTA) to the health care policy making process in light of increased healthcare costs. In Japan, a trial introduction of cost-effectiveness evaluations within the drug and medical device approval process was started following the FY2016 Revision of Medical Fee.
In order to construct a sustainable health care system that meets global standards, Japan must utilize the limited resources available to it as efficiently and effectively as possible and maximize the value attainable from healthcare services. At the next Breakfast Meeting, Dr. Ataru Igarashi, one of the few HTA professionals in Japan, will join us to explain what HTA is, how it evaluates the value of medicine, and how HTA outcomes can be reflected in policies, with examples from recent HTA use cases.
■Keywords:
Pharmacoeconomics, Health Economics Evaluation, Cost-effectiveness Evaluation, QALY (Quality Adjusted Life years), QOL (Quality of Life)
■About Dr. Igarashi:
Dr. Igarashi received his Ph.D. (Pharmacoeconomics/Pharmaceutical Economics) from the Endowed Laboratory of Drug Policy and Management in the Graduate School of Pharmaceutical Sciences of the University of Tokyo (2008). He is Co-President of the Health Outcome Research Institute (2010 – Present). He specializes in biostatistics, health economics, and pharmacoeconomics.
■ Reference book:
・‘What is Pharmacoeconomics?’ (Authors: Ataru Igarashi, Mari Sato)
http://goo.gl/pnXuCD
・Nikkei Medical Online Series ‘I can’t quite understand what Pharmacoeconomics is’ by Ataru Igarashi”
http://medical.nikkeibp.co.jp/inc/all/series/yakuzaikeizai/
*Registration will close at 23:59 pm on May 22. Participants will be selected by lot and will be informed of the result by the end of May 24. We appreciate your understanding.
**Please inform us if you would like to cancel by 17:00, May 30. If you cancel after this, participation fee might incur.
Registration deadline: 2016-05-22
Exhibition date:2016-06-02
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)